ROCO
1781
Market cap16mUSD
Oct 08, Last price
10.90TWD
1D
9.77%
1Q
-8.79%
Jan 2017
-44.10%
IPO
-59.55%
Name
Health&Life Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Health & Life Co., Ltd. is a global provider of medical devices. Established in 1996 and headquartered in New Taipei City, Taiwan, the company specializes in developing and distributing solutions for critical health sectors, including cardiovascular health, in-vitro diagnostics, and respiratory care. Its diverse product line encompasses advanced vibrating mesh nebulizers, blood pressure monitoring systems, infrared thermometers, and various hearing aid technologies.
Key people
Xunlu Xu
Deputy General Manager-Finance & Management · since 2009
Shufen Li
Head of Finance & Accounting, Corporate Governance Officer · since 2023
Yufeng Hong
Director
Shaohong Li
General Manager, Director · since 2004
Shuzhen Lian
Director · since 1999
Guohe Yang
Chairman of the Board, Chief Executive Officer · since 2021
Guoshuo Yang
Director · since 2025
Independent Director · since 2010
Shunqian Lin
Independent Director · since 2025
Independent Director · since 2010
Bin'an Wu
Independent Director · since 2022
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||